SG
SBLENDORIO GLENN Director
C-suite M
US US · SEC (Form 4)
Discover the full record of transactions filed by SBLENDORIO GLENN, Director. Insider active across 3 companies, notably Intercept Pharmaceuticals, INC.. In total, 21 disclosures have been recorded. Total volume traded: €854k. The latest transaction was filed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations 21 total
012,671 shares 0
Common Stock
SEC:0001209191-22-035852:0 · 9 Jun 2022
07,737 shares 0
Common Stock
SEC:0001104659-22-065913:0 · 25 May 2022
€854,425 50,000 shares @ €17.0885 87.7% of flow
Common Stock
SEC:0001410939-22-000048:0 · 4 Apr 2022
€3,195 1,213 shares @ €2.634 0.3% of flow
Common Stock
SEC:0001410939-22-000040:0 · 30 Mar 2022
€50,137 18,775 shares @ €2.6704 5.1% of flow
Common Stock
SEC:0001410939-22-000031:0 · 25 Mar 2022
€9,215 3,479 shares @ €2.6488 0.9% of flow
Common Stock
SEC:0001410939-22-000023:0 · 18 Mar 2022
€64,924 15,000 shares @ €4.3282 0.0014% mcap 100.0% of flow
Common Stock
SEC:0001209191-22-016793:0 · 4 Mar 2022
€259 100 shares @ €2.588 0.9% of flow
Common Stock
SEC:0001104659-22-000502 · 30 Dec 2021
€259 100 shares @ €2.588 0.0% of flow
Common Stock
SEC:0001104659-22-000502:0 · 30 Dec 2021
€28,471 22,163 shares @ €1.2846 99.1% of flow
Common Stock
SEC:0001104659-21-153685 · 22 Dec 2021
€28,471 22,163 shares @ €1.2846 2.9% of flow
Common Stock
SEC:0001104659-21-153685:0 · 22 Dec 2021
36,658 shares
Common Stock
SEC:0001104659-21-152293 · 18 Dec 2021
36,658 shares
Common Stock
SEC:0001104659-21-152293:0 · 18 Dec 2021
22,950 shares
Common Stock
SEC:0001104659-21-149631 · 12 Dec 2021
22,950 shares
Common Stock
SEC:0001104659-21-149631:0 · 12 Dec 2021
23,750 shares
Common Stock
SEC:0001104659-21-149246 · 9 Dec 2021
23,750 shares
Common Stock
SEC:0001104659-21-149246:0 · 9 Dec 2021
010,115 shares 0
Common Stock
SEC:0001209191-21-040395 · 10 Jun 2021
010,115 shares 0
Common Stock
SEC:0001209191-21-040395:0 · 10 Jun 2021
07,029 shares 0
Common Stock
SEC:0001104659-21-075223 · 27 May 2021
07,029 shares 0
Common Stock
SEC:0001104659-21-075223:0 · 27 May 2021
About SBLENDORIO GLENN Glenn Sblendorio is an executive at Intercept Pharmaceuticals, Inc.